Search Results - "Arvanitakis, Alexandros"

PB2059: SENSITIVITY AND SUBGROUP ANALYSES FURTHER SUPPORT CLINICAL SIMILARITY IN EFFICACY BETWEEN ABP 959 AND ECULIZUMAB REFERENCE PRODUCT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) by Kulasekararaj, Austin, Lanza, Francesco, Arvanitakis, Alexandros, Langemeijer, Saskia, Chonat, Satheesh, Cao, Jia, Chow, Vincent, Henary, Haby

Get full text

A comparison of MyPKFiT and WAPPS‐Hemo as dosing tools for optimizing prophylaxis in patients with severe haemophilia A treated with Octocog alfa by Arvanitakis, Alexandros, Berntorp, Erik, Astermark, Jan

“…Introduction MyPKFiT and the Web‐Accessible Population Pharmacokinetic service—Hemophilia (WAPPS‐Hemo) are web‐based population‐based applications developed…”
Get full text

Primary prophylaxis implementation and long-term joint outcomes in Swedish haemophilia A patients by Arvanitakis, Alexandros, Jepsen, Caroline, Andersson, Nadine G, Baghaei, Fariba, Astermark, Jan

“…Primary prophylaxis is the gold standard in severe haemophilia A (SHA) but time to escalate the prophylaxis regimen varies. Assess prophylaxis implementation…”
Get full text

Efficacy of Parallel and Crossover Analysis As Well As Pharmacokinetic Similarity Were Confirmed between ABP 959 and Eculizumab Reference Product in Patients with PNH by Kulasekararaj, Austin, Lanza, Francesco, Arvanitakis, Alexandros, Langemeijer, Saskia MC, Chonat, Satheesh, Cao, Jia, Chow, Vincent, Henary, Haby

“…Introduction: ABP 959, a biosimilar to eculizumab reference product (RP), binds to the human complement component 5 protein to inhibit terminal complement…”
Get full text

Impact of timing of prophylaxis commencement, F8 genotype and age on factor consumption and health‐related quality of life in patients with severe haemophilia A by Arvanitakis, Alexandros, Holme, Pål Andre, Berntorp, Erik, Astermark, Jan

“…Introduction The timing of prophylaxis and F8 genotype can impact treatment outcomes in adults with severe haemophilia A (HA). Aim To investigate how F8…”
Get full text

Sickle cell disease - common and dangerous complications by Björkman, Hedvig, Fager Ferrari, Marcus, Arvanitakis, Alexandros, Kjellander, Christian

“…Sickle cell disease is a genetic disorder affecting hundreds of thousands of people worldwide. This article will focus on the most common and dangerous acute…”
Get more information

Clinical outcome and adherence rate in Scandinavian patients with intermediate‐intensity prophylaxis before and after the switch of standard half‐life FVIII products to BAY 81–8973 by Arvanitakis, Alexandros, Holme, Pål Andre, Berntorp, Erik, Astermark, Jan

“…Introduction Treatment optimization in haemophilia A can be achieved by choice of FVIII product and knowledge of pharmacokinetics (PK), phenotype and…”
Get full text

Selective killing of candidate AML stem cells by antibody targeting of IL1RAP by Askmyr, Maria, Ågerstam, Helena, Hansen, Nils, Gordon, Sandra, Arvanitakis, Alexandros, Rissler, Marianne, Juliusson, Gunnar, Richter, Johan, Järås, Marcus, Fioretos, Thoas

“…IL1RAP, a co-receptor for interleukin (IL)-1 and IL-33 receptors, was previously found to be highly upregulated on candidate chronic myeloid leukemia stem…”
Get full text

Efficacy and Safety of Biosimilar Candidate ABP 959 As Compared with Eculizumab Reference Product in Paroxysmal Nocturnal Hemoglobinuria by Kulasekararaj, Austin, Lanza, Francesco, Arvanitakis, Alexandros, Langemeijer, Saskia M.C., Chonat, Satheesh, Chow, Vincent, Pan, Jean, Saportas, Yaneth, Hanes, Vladimir, Henary, Haby

Get full text

Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria by Kulasekararaj, Austin, Lanza, Francesco, Arvanitakis, Alexandros, Langemeijer, Saskia, Chonat, Satheesh, Tombak, Anil, Hanes, Vladimir, Cao, Jia, Miller, Mieke Jill, Colbert, Alexander, Shander, Benjamin, Mytych, Daniel T., Chow, Vincent, Henary, Haby

“…ABP 959 is a biosimilar to the eculizumab reference product (RP), which is approved for the treatment of patients with paroxysmal nocturnal hemoglobinuria…”
Get full text

Comprehensive Prospective Next Generation Sequencing of Acute Myeloid Leukemia by Orsmark-Pietras, Christina, Lilljebjörn, Henrik, Rissler, Marianne, Lazarevic, Vladimir, Arvanitakis, Alexandros, Ehinger, Mats, Juliusson, Gunnar, Fioretos, Thoas

“…Acute Myeloid Leukemia (AML) is a heterogeneous disease with poor overall five-year survival of less than 30%. Current risk stratification is largely based on…”
Get full text

Recursion and evolution: Part II by Arvanitakis, Alexandros

“…We examine the question of whether it is possible for a diagonalizing system, to learn to use environmental reward and punishment as an information, in order…”
Get full text

The Neopalatial -Final Palatial transition at Kommos in southcentral Crete: Evidence for connections with Knossos and for the extent of Mycenaean influence in the LM II -IIIA1 ceramic record by Arvanitakis, Jan Alexandros

“…According to the prevailing view today, local ceramic production on Crete at sites outside the Knossos area came under considerable Knossian influence by LM…”
Get full text

The emergence of palatial society in Late Bronze Age Argolis by Arvanitakis, Jan Alexandros

“…This thesis proposes to evaluate the impact of factors such as trade, circumscribed resources, and growing militarism upon the development of social complexity…”
Get full text